How deadly is Lung cancer?

['Ehendu ko kuatiarogue']

Mba'eichaite pevépa oporombohasa'asy cáncer de pulmón?

Cáncer de pulmón niko peteî mba'asy oporojukáva, ha hetaiterei tapicha omano.

Ha'e hína mba'asy hetave oporojukáva yvórape, hetave cáncer de mama, próstata ha colon-gui oñondive.

Po ary ohasáva cáncer de pulmón rehe ha'e 15% ha kóva ogueru peteî káda mbohapy káso de muerte cáncer-gui.

Tuguyasuka káma akytã'aíre omanóva retakue oguejy kuimba'e apytépe sa'ive rupi opitáva, katu ojupive kuña apytépe.

Jepéramo sa'ive opita, cáncer de pulmón ha'e gueteri peteĩ mba'asy guasu salud pública-pe g̃uarã, ha ojehejarei ramo pe tabaquismo añónte ndaikatumo'ãi oñepohãno.

['Jehechapy']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Chen WQ, Zhang SW, Zou XN, Zhao P: [An analysis of lung cancer mortality in China, 2004 - 2005]. Zhonghua Yu Fang Yi Xue Za Zhi. 2010, 44 (5): 378-82.

New M, Keith R: Early Detection and Chemoprevention of Lung Cancer. F1000Res. 2018, 7 (): 61.

Chu YJ, Liu QY, Hou C, Yu SY: Blood selenium concentration in residents of areas in China having a high incidence of lung cancer. Biol Trace Elem Res. 1984, 6 (2): 133-7.

Yamaguchi N, Mochizuki-Kobayashi Y, Utsunomiya O: Quantitative relationship between cumulative cigarette consumption and lung cancer mortality in Japan. Int J Epidemiol. 2000, 29 (6): 963-8.

Kazerouni N, Alverson CJ, Redd SC, Mott JA, Mannino DM: Sex differences in COPD and lung cancer mortality trends--United States, 1968-1999. J Womens Health (Larchmt). , 13 (1): 17-23.

Phillips AJ: An analysis of the increase in lung cancer in Canada. Can Med Assoc J. 1966, 95 (23): 1172-4.

['Ñemboyke: pohã']

["Ko página web niko ñehekombo'e ha marandu rehegua añónte, ndaha'éi ñeporandu térã ñepytyvõ pohãnohárape."]

["Ko marandu oñeme'ẽva ndojeporúi va'erã ojeikuaa térã oñepohano hag̃ua peteĩ problema de salud térã mba'asy, ha umi tapicha ohekáva consejo médico ha'eñoháme oñe'ẽva'erã peteĩ pohanohára ikatupyrýva ndive."]

["Ejesareko ta'ãngamýi ñandutigua omoheñóiva mbohovái porandukuérape, noĩporãi ojeipapávo papapy rehegua, techapyrã, tapichakuéra hasýva peteĩ mba'asýpe."]

["Akóinte eheka ne pohãnohára térã ambue pohanohára ikatupyrýva ñe'ẽ peteĩ mba'asýpe. Ani araka'eve remboyke térã reha'arõ'ỹ rehekávo ñe'ẽ pohanohára ikatupyrýva ñe'ẽ remoñe'ẽre ko ñanduti rendápe. Reimo'ãramo ikatuha reikotevẽ peteĩ mba'e hasýva, ehenoikuaa 911 térã tereho pya'e tasyópe. Ko ñanduti renda térã ijeporu ndojapói mba'eveichagua pohanohára ha hasýva jokupyty. BioMedLib, imba'apohára térã oimeraẽ tapicha oipytyvõva ko ñanduti rendápe, nomboajéi mba'eve, he'íva térã he'iséva, marandu oĩva ko'ápe térã ijeporu."]

['Copyright: Copyright']

["Pe Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (DMCA) ome'ẽ recurso umi copyright járape ogueroviáva umi mba'e ojehechaukáva Internet-pe opokovaiha iderecho rehe EE.UU. léi jehaiporãmby rehegua rupive. "]

["Rogueroviáramo añetehápe oimeraẽ mba'e térã tembiporu ojepurukuaáva ore ñanduti renda térã tembipurupyahu rupive opyrũha ne derécho rehe, nde (térã ne rembijokuái) ikatu oremondo peteĩ ñemomarandu ojerurévo ojeipe'a hag̃ua upe mba'e térã tembiporu, térã ojejokopa hag̃ua ijeike. "]

['Umi ñemomarandu oñemog̃uahẽva\'erã kuatia rupive, correo electrónico rupive (ojehecháta "Contacto" pe).']

["DMCA ojerure ne ñemomarandu rehe ejaposégui mba'evai ejaposéva rehe toike ko'ã mba'e: (1) tembiapo ojejaposéva rehegua ha'éva mba'evai; (2) jehaipy ha mba'ekuaarã ome'ẽva oréve jehaipyre ha'éva mba'evai ha ome'ẽva oréve pa'ũ rojuhu hag̃ua; (3) ne ñanduti veve, ne rendaite, ne pumbyry papapy ha ne ñanduti veve; (4) ñe'ẽme'ẽ erekóva rejeroviaha pe mba'evai ejaposéva rehe ndojeruréiha mba'evai apohára, imaranduhára térã léi."]

["5. peteî declaración nde rejapóva, remoîva nde réra ha remoîva'erâha nde jurúpe, umi mba'e oîva ñemomarandúpe oîmbaha añetehápe ha rerekoha pokatu remoañete haguâ umi derecho oje'éva nde rehe ojepoko vaiha;"]

["ha (6) peteĩ firma física térã electrónica copyright jára rehegua térã peteĩ tapicha omoneĩva oporoñemomba'e hag̃ua copyright jára rérape. "]

["Ndoikéi ramo opaite ko'ã mba'e ikatu ombohape nde denuncia ñemboguata."]

['Ñemboheraguapy']

["Remba'eporanduséramo térã ereko hag̃ua ne remiandu ehai oréve."]

How deadly is lung cancer?

Lung cancer is a very deadly disease, with a high mortality rate.

It is the leading cause of cancer deaths worldwide, accounting for more deaths than breast, prostate, and colorectal cancers combined.

The five-year survival rate for lung cancer is only 15%, and it is responsible for one in every three cancer deaths.

The mortality rate for lung cancer has been decreasing in men due to a decrease in smoking prevalence, but it has been increasing in women.

Despite the drop in smoking rates, lung cancer remains a significant public health epidemic, and smoking cessation alone will not cure it.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.